“drugs” Archives

in
Entry Author Date Location
Connect Hands Out 8 Most Innovative New Product Awards 12/02/16 San Diego
Goldman Funnels $51M Into Cloud Tech Company That Fights Fake Drugs 11/30/16 Boston
Tetra Discovery Raises $10M Series A, Advances Alzheimer’s Drug 11/30/16 Detroit Ann Arbor
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
Amyloid Hypothesis Takes a Hit As Lilly’s Alzheimer’s Drug Fails Again 11/23/16 Indiana
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge 11/22/16 National
Acorda Leans on Parkinson’s Drugs After Post-Stroke Study Fails 11/21/16 New York
Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study 11/17/16 New York
How to Lower Drug Prices, Improve Care, and Save Pharma 11/17/16 San Diego
Keeping Lead in Migraine Drug Race, Amgen Touts Data, Preps FDA Filing 11/16/16 San Francisco
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Corbus Shares Climb on Early Data For Inflammation Drug 11/14/16 Boston
New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease 11/07/16 Boston
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Celldex, Aiming For More Cancer Drug Combos, Pays $62.5M For Kolltan 11/01/16 New York
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
Allergan Snags Rhythm’s Diabetes-Related GI Drug for $200M 10/27/16 Boston
Alkermes Eyes FDA Nod After Retooled Study Yields Desired Results 10/20/16 Boston
Roundup: J&J and AT&T Grow in Houston, Inspyr and Meshify Move On 10/19/16 Texas
Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction 10/17/16 New York
Weeks After Deal, FDA Slaps Clinical Hold on Regeneron/Teva Pain Drug 10/17/16 New York
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
California Accelerators Enroll Startups Targeting Cannabis Industry 10/12/16 San Diego
IT-Biotech Hybrid Zymergen Raises $130M Round Led By SoftBank 10/11/16 San Francisco
San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals 10/11/16 San Diego
How Doctors Think About Drug Prices 10/11/16 Boston
Defying Patient Pressure, Anthem Says No to Sarepta’s Duchenne Drug 10/07/16 Boston
Post FDA Approval, Sarepta Wheels and Deals for Combo Duchenne Drugs 10/04/16 Boston
Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns 10/03/16 Boston
Gates Grant Helps Sirenas Extend Hunt for Drugs From Sea Organisms 10/03/16 San Diego
Page 1 of 91 next page »